Rituximab therapy modulates IFN-gamma and IL-4 gene expression in a patient with acquired haemophilia A.
Kruse-Jarres
Rebecca
R
Fang
Jian
J
Leissinger
Cindy A
CA
Ganapamo
Frédéric
F
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D007371:Interferon-gamma / Q000096:biosynthesis*; D015847:Interleukin-4 / Q000096:biosynthesis*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D015847:Interleukin-4; D000069283:Rituximab; D007371:Interferon-gamma